BioPharmaTrend
News
All Topics
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
  • NeuroTech
  • Interviews
  • Business Intelligence
  • Case Studies
Intelligence
  • Business Intelligence
  • Case Studies
  • Lab
  • Membership
About
  • At a Glance
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Newsletter
Login/Join
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
  • NeuroTech

Andrii Buvailo, PhD

Science & Tech Communicator at www.AndriiBuvailo.com

Co-founder, BiopharmaTrend

   

Dr. Andrii Buvailo is a pharmaceutical industry analyst, tech scout and writer with a focus on artificial intelligence (AI) in drug discovery and biotech, digital transformation of pharma industry, and the advent of novel therapeutic modalities.

Andrii’s reports touch upon disruptive biotech startups, venture capital deals, drug discovery IPOs and platform companies. His articles were published on Forbes, and market research reports were referenced by some of the leading organizations (e.g. Deloitte).

Andrii is an ex-Enamine veteran, having served for the company as Director of E-commerce and Marketing for more than 8 years. Enamine is a global supplier of fine chemicals and compound libraries for the pharmaceutical industry.

Before venturing into the pharmaceutical industry and media entrepreneurship, Andrii used to work as a scientist. He holds PhD in Physical Chemistry, and has research experience in bioinorganic and supramolecular chemistry, thin polymer films, nanomaterials, and sensors.

Andrii is Ukrainian, currently based in Spain.


Recent articles from Andrii

From Gene Editing to Pathway Design: How AI is Transforming Synthetic Biology

Oct. 20, 2023   
From Gene Editing to Pathway Design: How AI is Transforming Synthetic Biology

Synthetic biology refers to the purposeful design and construction of new biological components, devices, and systems, as well as the re-engineering of existing natural biological systems to serve practical functions. It extends the principles of genetic engineering, adopting a design-driven …

Three Big Ideas in Aging Research That Could Shift the Therapeutic Landscape

Nov. 1, 2024      Business Intelligence
Three Big Ideas in Aging Research That Could Shift the Therapeutic Landscape

Disclaimer: this post is not medical advice; the content of the post is for informational and educational purposes only.  

Over the past decade, aging research has transitioned from a mostly fundamental science practice, including a landmark introduction of 9 hallmarks …

7 Promising RNA Biotech Companies To Watch in 2026

June 16, 2024   
7 Promising RNA Biotech Companies To Watch in 2026

For many years the focus of therapeutic developments and scientific research was directed at the genome and proteins. Yet, there is a completely different level of cell regulation – transcriptome level, presented by Ribonucleic acids (RNAs). RNA molecules are not just …

Takeda Expands AI-Driven Antibody Design Partnership with Nabla Bio in a Billion-Dollar Deal

Oct. 14, 2025      News
Takeda Expands AI-Driven Antibody Design Partnership with Nabla Bio in a Billion-Dollar Deal

U.S. biotech company Nabla Bio has signed a second major research partnership with Japan’s Takeda Pharmaceutical Co. (4502.T), expanding their collaboration in artificial intelligence-driven drug discovery. The new multi-year agreement builds on an initial collaboration launched in 2022 and could …

15 Useful Mobile Apps For Life Scientists

Sept. 1, 2018   
15 Useful Mobile Apps For Life Scientists

Nowadays, mobile devices are ubiquitous with an estimated number of smartphones and tablet PCs to exceed two billion globally.

The availability of internet connection in most public places, powerful processors, and user-friendly touch screen technologies make mobile devices useful not …

How Big Pharma Adopts AI To Boost Drug Discovery

July 6, 2023   
How Big Pharma Adopts AI To Boost Drug Discovery
(Last updated: October 2025)

Since 1950, when Alan Turing introduced the concept of 'thinking machines', artificial intelligence has steadily advanced—from the rise of neural networks in the 1980s to the release of OpenAI’s GPT-3 in 2020, which paved the …

How Lantern Pharma's AI-driven Approach Enables Precision Oncology

June 13, 2023   
How Lantern Pharma's AI-driven Approach Enables Precision Oncology

Lantern Pharma’s AI-driven drug discovery platform RADR® enables value creation across multiple dimensions of the oncology drug development process: from the expansion of therapeutic indications and the identification of drug combinations for use in precision oncology, as well as the …

12 Emerging Companies to Watch in Neurotech Space

Aug. 4, 2024   
12 Emerging Companies to Watch in Neurotech Space

Brain-computer interface (BCI) technologies are rapidly becoming the spotlight of the neurotech industry, with Neuralink at the forefront. Recently, Neuralink implanted its first brain chip in a human, marking a significant milestone in human-computer interaction. This implant allows users …

Singapore’s Nanyang Biologics Plans to Go Public on Nasdaq in US $1.5 Billion SPAC Deal

Oct. 2, 2025      News
Singapore’s Nanyang Biologics Plans to Go Public on Nasdaq in US $1.5 Billion SPAC Deal

Singapore’s Nanyang Biologics (NYB), a company working at the intersection of biodiversity and artificial intelligence, is preparing to list on Nasdaq through a US$ 1.5 billion business combination with RF Acquisition Corp II, a U.S. special purpose acquisition company.

The …

17 Companies Pioneering AI Foundation Models in Pharma and Biotech

June 19, 2024      Business Intelligence
17 Companies Pioneering AI Foundation Models in Pharma and Biotech

Foundation models represent a relatively new paradigm in artificial intelligence (AI), revolutionizing how machine learning models are developed and deployed.

Foundation models are a class of large-scale machine learning models, typically based on deep learning architectures such as transformers, that are …

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Newsletter
  • Business Intelligence
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Advertise
  • Lab Access
  • Lab Membership
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.